Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease
James, Joyce K.,Savall, Traci L.,Eichelberger, Shawn R.
申请号：
AU2008325141
公开号：
AU2008325141B2
申请日:
2008.11.07
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea,or a pharmaceutically acceptable salt or solvate thereof, to human patients.Specifically, dosing, dosing schedules or dosing regimens are provided herein.Further, pharmaceutical formulations are provided. Methods of treating proliferativediseases or FLT-3 mediated diseases in humans are also provided.
